Status:
UNKNOWN
Probiotic Supplementation in the Dysbiosis of Bowel Preparation
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Microbial Colonization
Irritable Bowel Syndrome
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Significant changes in gut microbiota was noted after the high-volume bowel preparation with PEG before colonoscopy. The dynamic changes were found to be short-term. However, the perturbation pattern ...
Detailed Description
Objectives: Colonoscopy is widely used for identification and treatment of colon polyps and intestinal symptoms. High-volume polyethylene glycol (PEG) bowel preparation prior to colonoscopy causes sig...
Eligibility Criteria
Inclusion
- Adults age \>20
- Undergoing colonofibroscopy (CFS) with PEG bowel preparation
Exclusion
- Inadequate bowel preparation
- Subjects with active cancer or IBD (inflammatory bowel disease)
- Subjects with history of abdominal surgery (including stomach, gallbladder, pancreas, small bowel, large bowel)
- Subjects who take medication related to gastrointestinal motility within 1 months
- Subjects who take antibiotics or probiotics within 1 months
- Subjects under pregnancy
- Allergic or intolerance to the study medication
- Refused to randomization
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04774042
Start Date
March 1 2021
End Date
January 1 2023
Last Update
February 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.